Aviva’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.36M | Buy |
|
|||||
|
2025
Q1 | $496K | Sell |
|
|||||
|
2024
Q4 | $467K | Hold |
|
|||||
|
2024
Q3 | $500K | Sell |
|
|||||
|
2024
Q2 | $1.04M | Buy |
|
|||||
|
2024
Q1 | $626K | Buy |
|
|||||
|
2023
Q4 | $674K | Sell |
|
|||||
|
2023
Q3 | $621K | Sell |
|
|||||
|
2023
Q2 | $2.32M | Buy |
|
|||||
|
2023
Q1 | $904K | Sell |
|
|||||
|
2022
Q4 | $6.73M | Buy |
|
|||||
|
2022
Q3 | $2.26M | Sell |
|
|||||
|
2022
Q2 | $2.89M | Sell |
|
|||||
|
2022
Q1 | $2.78M | Sell |
|
|||||
|
2021
Q4 | $4.82M | Sell |
|
|||||
|
2021
Q3 | $4.32M | Sell |
|
|||||
|
2021
Q2 | $4.89M | Sell |
|
|||||
|
2021
Q1 | $4.61M | Sell |
|
|||||
|
2020
Q4 | $5.39M | Buy |
|
|||||
|
2020
Q3 | $4.43M | Sell |
|
|||||
|
2020
Q2 | $9.68M | Sell |
|
|||||
|
2020
Q1 | $9.11M | Buy |
|
|||||
|
2019
Q4 | $7.35M | Buy |
|
|||||
|
2019
Q3 | $4.26M | Sell |
|
|||||
|
2019
Q2 | $5.59M | Sell |
|
|||||
|
2019
Q1 | $5.92M | Buy |
|
|||||
|
2018
Q4 | $5.64M | Sell |
|
|||||
|
2018
Q3 | $8.22M | Sell |
|
|||||
|
2018
Q2 | $8.27M | Sell |
|
|||||
|
2018
Q1 | $7.22M | Sell |
|
|||||
|
2017
Q4 | $8.67M | Sell |
|
|||||
|
2017
Q3 | $10.1M | Buy |
|
|||||
|
2017
Q2 | $9.66M | Buy |
|
|||||
|
2017
Q1 | $9.13M | Sell |
|
|||||
|
2016
Q4 | $9.06M | Buy |
|
|||||
|
2016
Q3 | $9.48M | Buy |
|
|||||
|
2016
Q2 | $7.32M | Buy |
|
|||||
|
2016
Q1 | $6.5M | Buy |
|
|||||
|
2015
Q4 | $8.16M | Sell |
|
|||||
|
2015
Q3 | $8.23M | Sell |
|
|||||
|
2015
Q2 | $11M | Sell |
|
|||||
|
2015
Q1 | $10.2M | Buy |
|
|||||
|
2014
Q4 | $5.15M | Buy |
|
|||||
|
2014
Q3 | $4.1M | Buy |
|
|||||
|
2014
Q2 | $3.52M | Buy |
|
|||||
|
2014
Q1 | $3.67M | Buy |
|